The cost of drug-carrying microsphere intervention is about 50,000 yuan, and the price is only relative. Because the patients’ physique is different, the diseases they suffer from are also different, plus the different level of each hospital, regional differences, medical insurance policy and other influences on the standard of its charges are also different, so the cost of treatment will have a certain degree of deviation. The specific treatment cost of drug-carrying microsphere intervention should be based on the charge of the hospital where the patient is treated. Drug-carrying microsphere intervention has achieved a series of effects in the treatment of tumors, and it has a wide range of indications, and it can be used in the treatment of liver tumors, kidney and adrenal tumors, breast tumors and so on, which is especially suitable for patients with hepatocellular carcinoma. Compared with classical interventional procedures such as transhepatic artery cannulation, chemoembolization, etc., patients recover faster, have fewer side effects, are less traumatized and have more reliable efficacy.